This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights MetLife, Prudential Financial, Hartford Financial, MGIC Investment and Radian Group
by Zacks Equity Research
MetLife, Prudential Financial, Hartford Financial, MGIC Investment and Radian Group are included in this Analyst Blog.
MetLife (MET) Up 4.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Dividend-Paying Multiline Insurers for a Stable Portfolio
by Tanuka De
Multiline insurers like MetLife (MET), Prudential Financial (PRU), The Hartford Financial (HIG), MGIC Investment Corporation (MTG) and Radian Group (RDN), with an impressive dividend history, offer a breather amid volatility.
MetLife (MET) Extends Legal Plan to Benefit Federal Families
by Zacks Equity Research
MetLife (MET) puts its foot forward to assist Federal Families in legal matters by making the Federal Legal plan available to them.
Zacks Industry Outlook Highlights MetLife, American International Group, Prudential Financial, MGIC Investment and Radian Group
by Zacks Equity Research
MetLife, American International Group, Prudential Financial, MGIC Investment and Radian Group have been highlighted in this Industry Outlook article.
Insurance ETFs Rallying on Solid Q3 Earnings
by Sweta Killa
A slew of solid earnings from the leading players in the insurance industry added to the strength as some of the prominent players surpassed estimates for both earnings and revenues.
5 Multiline Insurers to Watch Amid High Inflation and Rate Rise
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and rate rise are expected to aid multiline insurers like MET, AIG, PRU, MTG and RDN.
MetLife (MET) Q3 Earnings Beat Estimates on Strong Volume Growth
by Zacks Equity Research
MetLife (MET) repurchases $674 million worth of shares during the third quarter.
MetLife (MET) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 2.54% and 19.12%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
EverQuote (EVER) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 51.22% and 10.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q3 Earnings Due on Nov 2: MET, ALL & LNC
by Kaibalya Pravo Dey
Interest rate hikes and favorable renewals are likely to aid insurers' Q3 results, offset by rising costs and catastrophe losses. MET, ALL and LNC will release earnings on Nov 2.
MetLife (MET) to Post Q3 Earnings: Here's What to Expect
by Zacks Equity Research
MetLife's (MET) third-quarter results are likely to reflect increased premiums but lower profits in Retirement Income Solutions.
Analysts Estimate MetLife (MET) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights MetLife, Prudential Financial, Reinsurance Group of America, Marsh & McLennan Companies and Aflac
by Zacks Equity Research
MetLife, Prudential Financial, Reinsurance Group of America, Marsh & McLennan Companies and Aflac are included in this Analyst Blog.
5 Insurers Set to Outshine Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help MET, PRU, RGA, MMC, and AFL outperform Q3 earnings estimates.
Why MetLife (MET) Could Beat Earnings Estimates Again
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should You Invest in the iShares U.S. Insurance ETF (IAK)?
by Zacks Equity Research
Sector ETF report for IAK
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Finance
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
5 Dividend-Paying Multiline Insurers That Ensure Stable Income
by Tanuka De
Multiline insurers like MetLife (MET), Prudential Financial (PRU), The Hartford Financial (HIG), Old Republic International (ORI) and Radian Group (RDN), which have an impressive dividend history, offer a breather amid volatility.
This 1 Finance Stock Could Beat Earnings: Why It Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
MetLife (MET) Adds Benefits as a Means to Advance Dental Plan
by Zacks Equity Research
MetLife (MET) unveils a dental plan-related incentive, promising to expand rewards by reducing out-of-pocket expenses of employees who opt for regular dental diagnosis.
Why Is MetLife (MET) Up 1.6% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MetLife (MET) Eyes ESG Investment Manager AIM Acquisition
by Zacks Equity Research
The AIM acquisition will likely advance MetLife's (MET) capabilities to deliver long-term risk-adjusted returns to clients while enhancing ESG investment and reporting portfolio.
Should You Invest in the iShares U.S. Insurance ETF (IAK)?
by Zacks Equity Research
Sector ETF report for IAK
Zacks Industry Outlook Highlights MetLife, American International, The Hartford Financial Services, Assurant and Radian Group
by Zacks Equity Research
MetLife, American International, The Hartford Financial Services, Assurant and Radian Group are part of Zacks Industry Outlook article.